Listed@ASX
Your go-to source for ASX IPO and listed company news, insights and analysis
Read below to view the latest articles, featuring a fantastic breadth of interviews with leading CEOs from ASX-listed companies and more.
With a new capital stack and a commitment to return to paying dividends, Ryman Healthcare CEO Naomi James reflects on the company’s life after its 2025 ASX listing and the path ahead.
Learn why timing and preparation are so important for IPOs, our 2025 IPO year in review and check out the excitement from our 2025 listing ceremonies.
The resurgence of the initial public offering market is an important opportunity for the many companies that need capital to grow. But a successful listing requires careful preparation. This Listed@ASX roundtable explores what this involves.
A 37% increase in listings with an average return of 24.2% saw more than $38 billion of new market capitalisation added to the market. Read more about the resurgent year for ASX listings and IPOs.
Check out some of the action from listing ceremonies in 2025, including Virgin, GemLife, Carma, Chemist Warehouse, Sigma and more!
Operating in an industry poised for unprecedented growth, a dual-listing on ASX was the natural progression for Ryman Healthcare. Read more about their journey and what’s next!
Giri Tenneti speaks to Australian Clinical Labs CEO, Melinda McGrath.
Giri Tenneti speaks to Richard White, Founder and CEO of Wisetech Global
For more information contact the ASX Listings team.
Sign up for Listed@ASX
Your go-to source for ASX IPO and listed company news, insights and analysis - straight to your inbox three time a year.
For more information contact the ASX Listings team.
The views, opinions or recommendations of the author in this article are solely those of the author and do not in any way reflect the views, opinions, recommendations, of ASX Limited ABN 98 008 624 691 and its related bodies corporate (“ASX”). ASX makes no representation or warranty with respect to the accuracy, completeness or currency of the content. The content is for educational purposes only and does not constitute financial advice. Independent advice should be obtained from an Australian financial services licensee before making investment decisions. To the extent permitted by law, ASX excludes all liability for any loss or damage arising in any way due to or in connection with the publication of this article, including by way of negligence.
